# XAGEW (Longevity Health Holdings, Inc.) - SEC EDGAR Financial Statements

> Longevity Health Holdings, Inc. reported $1.69M in revenue and a net loss of $6.83M for the trailing twelve months ended June 30, 2026 (down 21.4% year over year), with a 59.0% gross margin and a -343.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/XAGEW
- Markdown: https://convexityos.com/fundamentals/XAGEW.md
- SEC CIK: 0001842939
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001842939&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.69M | -21.4% YoY |
| Operating Income | TTM | -$5.79M | -343.6% margin |
| Net Income | TTM | -$6.83M | -404.8% net margin |
| Diluted EPS | TTM | -$4.83 | Split-adjusted |
| Free Cash Flow | TTM | -$3.34M | -198.2% FCF margin |
| Cash & ST Investments | Jun 30, 2026 | $35K | Total debt: $261K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.91M | $50K | $0 | -- | -- |
| Cost of Revenue | $818K | $6.4K | $0 | -- | -- |
| **Gross Profit** | $1.09M | $44K | $0 | -- | -- |
| Research & Development | $789K | $1.05M | $2.50M | $2.20M | -- |
| Total Operating Expenses | $8.20M | $5.04M | $5.94M | $5.51M | -- |
| **Operating Income** | -$7.11M | -$5.00M | -$5.94M | -$5.51M | -$467K |
| **EBITDA** | -$7.03M | -$4.92M | -$5.85M | -$5.41M | -- |
| Interest Expense | $18K | $29K | $34K | -- | -- |
| Income Before Tax | -$6.87M | -$10.75M | -$16.21M | -$9.05M | -$329K |
| Income Tax Expense | $36K | -$97K | $0 | $0 | $0 |
| **Net Income** | -$6.91M | -$10.37M | -$15.45M | -$9.05M | -$329K |
| Basic EPS | -$4.83 | -$14.56 | -$43.84 | -$164.26 | -- |
| **Diluted EPS** | -$4.83 | -$14.56 | -$43.84 | -$164.26 | -- |
| Basic Shares Outstanding | 1.4M | 712.1K | 367.0K | 58.5K | -- |
| Diluted Shares Outstanding | 1.4M | 712.1K | 367.0K | 58.5K | -- |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $396K | $392K | $473K | $426K | $504K | $510K | $17K | $21K |
| Cost of Revenue | $160K | $155K | $205K | $171K | $201K | $241K | $1.2K | $4.8K |
| **Gross Profit** | $236K | $237K | $268K | $254K | $303K | $270K | $16K | $16K |
| Research & Development | $73K | $55K | $104K | $228K | $229K | $197K | $189K | $332K |
| Selling, General & Admin | $873K | -- | -- | -- | $1.91M | -- | -- | -- |
| Total Operating Expenses | $960K | $1.57M | $2.54M | $1.73M | $2.16M | $1.78M | $1.02M | $1.44M |
| **Operating Income** | -$724K | -$1.33M | -$2.27M | -$1.47M | -$1.86M | -$1.51M | -$1.01M | -$1.42M |
| **EBITDA** | -$711K | -$1.31M | -$2.25M | -$1.45M | -$1.84M | -$1.48M | -$988K | -$1.40M |
| Interest Expense | -- | $3.5K | $5.6K | $5.1K | $2.6K | $5.0K | $7.5K | $7.1K |
| Income Before Tax | -$1.88M | -$1.43M | -$2.05M | -$1.43M | -$1.89M | -$1.51M | -$1.01M | -$2.88M |
| Income Tax Expense | $0 | $0 | $36K | $0 | $0 | $0 | -$97K | $0 |
| **Net Income** | -$1.88M | -$1.43M | -$2.08M | -$1.43M | -$1.89M | -$1.51M | -$914K | -$2.88M |
| Basic EPS | -$0.76 | -$0.75 | -- | -$0.83 | -$1.56 | -$1.52 | -- | -$4.13 |
| **Diluted EPS** | -- | -$0.75 | -- | -$0.83 | -$1.56 | -$1.52 | -- | -$4.13 |
| Basic Shares Outstanding | 2.5M | 1.9M | -- | 1.7M | 1.2M | 991.2K | -- | 696.8K |
| Diluted Shares Outstanding | -- | 1.9M | -- | 1.7M | 1.2M | 991.2K | -- | 696.8K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $707K | $157K | $2.91M | $128K | $774K |
| **Cash & Short-Term Investments** | $707K | $157K | $2.91M | $128K | $774K |
| Accounts Receivable, Net | $36K | $4.1K | $0 | $0 | -- |
| Inventory | $963K | $109K | $0 | $0 | -- |
| Other Current Assets | -- | -- | $0 | $28K | -- |
| **Total Current Assets** | $1.95M | $956K | $62.90M | $606K | $973K |
| Property, Plant & Equipment, Net | $102K | $114K | $193K | $255K | -- |
| Goodwill | -- | -- | -- | $0 | -- |
| Intangible Assets | $15K | $20K | $24K | $29K | -- |
| **Total Non-Current Assets** | $417K | $518K | $1.05M | $1.14M | $154.4M |
| **Total Assets** | $2.37M | $1.47M | $63.95M | $1.75M | $155.4M |
| Accounts Payable | $4.49M | $4.06M | $4.42M | $2.14M | -- |
| **Total Current Liabilities** | $7.92M | $5.88M | $38.50M | $7.30M | $330K |
| **Total Non-Current Liabilities** | $318K | $310K | $698K | $828K | $5.41M |
| **Total Liabilities** | $8.23M | $6.19M | $39.20M | $8.12M | $5.74M |
| **Total Debt (incl. Leases)** | $310K | $398K | $848K | $957K | -- |
| Common Stock | $178 | $70 | $2.3K | $897 | -- |
| Retained Earnings | -$75.78M | -$68.87M | -$58.50M | -$42.38M | -$4.76M |
| **Total Stockholders' Equity** | -$5.87M | -$4.71M | $24.75M | -$37.79M | -$29.58M |
| Total Equity | -$5.87M | -$4.71M | $24.75M | -$37.79M | -$29.58M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35K | $313K | $707K | $1.11M | $1.55M | $770K | $157K | $1.14M |
| **Cash & Short-Term Investments** | $35K | $313K | $707K | $1.11M | $1.55M | $770K | $157K | $1.14M |
| Accounts Receivable, Net | $20K | $49K | $36K | $47K | $54K | $95K | $4.1K | -- |
| Inventory | $607K | $735K | $963K | $1.01M | $1.17M | $1.38M | $109K | $98K |
| **Total Current Assets** | $712K | $1.26M | $1.95M | $2.84M | $3.24M | $2.79M | $956K | $1.88M |
| Property, Plant & Equipment, Net | $76K | $88K | $102K | $117K | $118K | $139K | $114K | $131K |
| Intangible Assets | $13K | $14K | $15K | $16K | $17K | $19K | $20K | $21K |
| **Total Non-Current Assets** | $344K | $380K | $417K | $455K | $478K | $544K | $518K | $557K |
| **Total Assets** | $1.06M | $1.64M | $2.37M | $3.30M | $3.72M | $3.34M | $1.47M | $2.44M |
| Accounts Payable | $5.04M | $5.05M | $4.49M | $4.17M | $4.59M | $4.60M | $4.06M | $4.21M |
| **Total Current Liabilities** | $9.59M | $8.35M | $7.92M | $6.84M | $6.91M | $6.60M | $5.88M | $6.17M |
| **Total Non-Current Liabilities** | $162K | $188K | $318K | $435K | $543K | $544K | $310K | $333K |
| **Total Liabilities** | $9.75M | $8.54M | $8.23M | $7.28M | $7.46M | $7.14M | $6.19M | $6.51M |
| **Total Debt (incl. Leases)** | $261K | $285K | $310K | $333K | $355K | $402K | $398K | $419K |
| Common Stock | $247 | $247 | $178 | $178 | $148 | $100 | $70 | $2.1K |
| Retained Earnings | -$79.09M | -$77.21M | -$75.78M | -$73.69M | -$72.26M | -$70.38M | -$68.87M | -$67.96M |
| **Total Stockholders' Equity** | -$8.70M | -$6.89M | -$5.87M | -$3.98M | -$3.74M | -$3.81M | -$4.71M | -$4.06M |
| Total Equity | -$8.70M | -$6.89M | -$5.87M | -$3.98M | -$3.74M | -$3.81M | -$4.71M | -$4.06M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$6.91M | -$10.65M | -$16.21M | -$9.05M | -$329K |
| Depreciation & Amortization | $79K | $83K | $97K | $94K | -- |
| Stock-Based Compensation | $693K | $827K | $668K | $636K | $0 |
| Change in Receivables | $44K | -$4.1K | -- | -- | -- |
| Change in Inventory | $371K | -$109K | -- | -- | -- |
| Change in Payables | $127K | -$359K | -$450K | $1.06M | -- |
| **Operating Cash Flow** | -$3.33M | -$3.89M | -$8.35M | -$3.43M | -$451K |
| Capital Expenditure | -$14K | -- | -$30K | -$7.2K | -- |
| **Free Cash Flow** | -$3.34M | -- | -$8.38M | -$3.44M | -- |
| **Investing Cash Flow** | -$164K | -$749K | -$30K | -$7.2K | -- |
| Common Stock Issued | $3.48M | $2.69M | -- | -- | -- |
| Share Repurchases | -- | -- | $0 | -$2.3K | -- |
| **Financing Cash Flow** | $4.04M | $1.89M | $11.16M | $3.55M | $155.7M |
| **Net Change in Cash** | $550K | -$2.76M | $2.78M | $116K | $774K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.88M | -$1.43M | -$2.08M | -$1.43M | -$1.89M | -$1.51M | -$914K | -$2.88M |
| Depreciation & Amortization | $13K | $15K | $16K | $16K | $22K | $24K | $18K | $18K |
| Stock-Based Compensation | $79K | $146K | $194K | $190K | $194K | $115K | $266K | $186K |
| Change in Receivables | $29K | -$12K | $10K | $8.0K | $40K | -$14K | -- | -- |
| Change in Inventory | $89K | $31K | $36K | $112K | $207K | $15K | -- | -- |
| Change in Payables | -$6.5K | $551K | $324K | -$456K | -$58K | $317K | -$156K | $119K |
| **Operating Cash Flow** | -$224K | -$485K | -$306K | -$1.43M | -$836K | -$753K | -$772K | -$907K |
| **Investing Cash Flow** | -- | -- | -$1 | $776 | -$15K | -$150K | $0 | $0 |
| Common Stock Issued | $0 | $190K | $0 | $86K | $1.76M | $1.64M | -- | -- |
| **Financing Cash Flow** | -$54K | $92K | -$96K | $991K | $1.63M | $1.52M | -$208K | -$154K |
| **Net Change in Cash** | -- | -$393K | -$402K | -$442K | $781K | $613K | -$980K | -$1.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.2% | 87.4% | -- | -- | -- |
| **Operating Margin** | -371.6% | -9933.8% | -- | -- | -- |
| **Net Profit Margin** | -361.0% | -20605.5% | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -62.4% | -- | -- |
| Return on Assets (ROA) | -291.7% | -703.4% | -24.2% | -517.6% | -0.2% |
| Current Ratio | 0.25x | 0.16x | 1.63x | 0.08x | 2.95x |
| Quick Ratio | 0.12x | 0.14x | 1.63x | 0.08x | 2.35x |
| Debt to Equity | -- | -- | 0.03x | -- | -- |
| **Revenue Growth (YoY)** | +3701.4% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +2390.3% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 59.0% | 59.2% | 57.2% | 57.9% | 57.5% | 56.0% | 87.4% | -- |
| **Operating Margin** | -343.6% | -386.2% | -371.6% | -401.0% | -550.6% | -914.1% | -9933.8% | -- |
| **Net Profit Margin** | -404.8% | -380.7% | -361.0% | -393.6% | -683.0% | -1534.4% | -20605.5% | -- |
| Return on Assets (ROA) | -647.0% | -415.9% | -291.7% | -173.9% | -193.2% | -257.8% | -703.4% | -257.9% |
| Current Ratio | 0.07x | 0.15x | 0.25x | 0.42x | 0.47x | 0.42x | 0.16x | 0.31x |
| Quick Ratio | 0.01x | 0.06x | 0.12x | 0.27x | 0.30x | 0.21x | 0.14x | 0.29x |
| **Revenue Growth (YoY)** | -21.4% | -23.2% | +2606.0% | +1975.5% | +3987.8% | -- | -- | -- |
| Gross Profit Growth (YoY) | -22.2% | -12.2% | +1547.7% | +1523.0% | +2416.3% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -129.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
